Celularity and GX Acquisition Corp. Announce Merger Agreement to Create a Publicly Listed Leader in Allogeneic Cellular Therapy
January 8,2021 Celularity Inc. is a clinical-stage biotechnology company, and leading the next evolution in cellular medicine with the development of off-the-shelf allogeneic therapies derived from the postpartum human placenta, and GX Acquisition Corp. (Nasdaq: GXGX), a special purpose acquisition company. Celularity announced they have entered into a definitive merger agreement pursuant to which GX […]